465 related articles for article (PubMed ID: 17101262)
1. Antimycobacterial activity of econazole against multidrug-resistant strains of Mycobacterium tuberculosis.
Ahmad Z; Sharma S; Khuller GK; Singh P; Faujdar J; Katoch VM
Int J Antimicrob Agents; 2006 Dec; 28(6):543-4. PubMed ID: 17101262
[TBL] [Abstract][Full Text] [Related]
2. In vitro and ex vivo antimycobacterial potential of azole drugs against Mycobacterium tuberculosis H37Rv.
Ahmad Z; Sharma S; Khuller GK
FEMS Microbiol Lett; 2005 Oct; 251(1):19-22. PubMed ID: 16143463
[TBL] [Abstract][Full Text] [Related]
3. Antituberculosis agents. VI. Activity of a new ciprofloxacin derivative against Mycobacterium avium and some drug-resistant strains of Mycobacterium tuberculosis.
Foroumadi A; Soltani F; Moshafi MH
Boll Chim Farm; 2002; 141(5):394-6. PubMed ID: 12481384
[TBL] [Abstract][Full Text] [Related]
4. Activity against multidrug-resistant Mycobacterium tuberculosis in Mexican plants used to treat respiratory diseases.
Jimenez-Arellanes A; Meckes M; Ramirez R; Torres J; Luna-Herrera J
Phytother Res; 2003 Sep; 17(8):903-8. PubMed ID: 13680821
[TBL] [Abstract][Full Text] [Related]
5. Antituberculosis agents. IX. In vitro antimycobacterial activity of N-(2-phenyl-2-oxoethyl) and N-[2-(4-fluorophenyl)-2-oxoethyl]ciprofloxacin derivatives against some drug-resistant strains of Mycobacterium tuberculosis and Mycobacterium avium isolates.
Foroumadi A; Soltani F
Boll Chim Farm; 2003; 142(6):248-50. PubMed ID: 14606264
[TBL] [Abstract][Full Text] [Related]
6. [The rates of resistance to second-line drugs in multidrug resistant Mycobacterium tuberculosis strains].
Kayali R; Cöplü N; Ceyhan I; Ocak F; Citil BE; Esen B
Mikrobiyol Bul; 2006; 40(1-2):1-7. PubMed ID: 16775950
[TBL] [Abstract][Full Text] [Related]
7. Preparation and in-vitro evaluation of 4-benzylsulfanylpyridine-2-carbohydrazides as potential antituberculosis agents.
Herzigová P; Klimesová V; Palát K; Kaustová J; Dahse HM; Möllmann U
Arch Pharm (Weinheim); 2009 Jul; 342(7):394-404. PubMed ID: 19536781
[TBL] [Abstract][Full Text] [Related]
8. In vitro activity of linezolid against multidrug-resistant Mycobacterium tuberculosis isolates.
Erturan Z; Uzun M
Int J Antimicrob Agents; 2005 Jul; 26(1):78-80. PubMed ID: 15950439
[TBL] [Abstract][Full Text] [Related]
9. [Resistance of Mycobacterium tuberculosis strains to antimycobacterial preparations].
Iavors'ka HV; Puhachevs'ka LP
Mikrobiol Z; 2006; 68(5):44-51. PubMed ID: 17388119
[TBL] [Abstract][Full Text] [Related]
10. The potential of azole antifungals against latent/persistent tuberculosis.
Ahmad Z; Sharma S; Khuller GK
FEMS Microbiol Lett; 2006 May; 258(2):200-3. PubMed ID: 16640573
[TBL] [Abstract][Full Text] [Related]
11. Antimycobacterial activity of Citrullus colocynthis (L.) Schrad. against drug sensitive and drug resistant Mycobacterium tuberculosis and MOTT clinical isolates.
Mehta A; Srivastva G; Kachhwaha S; Sharma M; Kothari SL
J Ethnopharmacol; 2013 Aug; 149(1):195-200. PubMed ID: 23816500
[TBL] [Abstract][Full Text] [Related]
12. Activity against drug resistant-tuberculosis strains of plants used in Mexican traditional medicine to treat tuberculosis and other respiratory diseases.
Camacho-Corona Mdel R; Ramírez-Cabrera MA; Santiago OG; Garza-González E; Palacios Ide P; Luna-Herrera J
Phytother Res; 2008 Jan; 22(1):82-5. PubMed ID: 17726732
[TBL] [Abstract][Full Text] [Related]
13. In vitro activity of linezolid against Mycobacterium tuberculosis strains isoalted from Western Turkey.
Ermertcan S; Hosgor-Limoncu M; Erac B; Tasli H; Cavusoglu C; Bozkurt H
Jpn J Infect Dis; 2009 Sep; 62(5):384-5. PubMed ID: 19762990
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and biological evaluation of new enantiomerically pure azole derivatives as inhibitors of Mycobacterium tuberculosis.
Castagnolo D; Radi M; Dessì F; Manetti F; Saddi M; Meleddu R; De Logu A; Botta M
Bioorg Med Chem Lett; 2009 Apr; 19(8):2203-5. PubMed ID: 19299129
[TBL] [Abstract][Full Text] [Related]
15. Preparation and in vitro evaluation of benzylsulfanyl benzoxazole derivatives as potential antituberculosis agents.
Klimesová V; Kocí J; Waisser K; Kaustová J; Möllmann U
Eur J Med Chem; 2009 May; 44(5):2286-93. PubMed ID: 18694614
[TBL] [Abstract][Full Text] [Related]
16. Wild-type distributions of seven oral second-line drugs against Mycobacterium tuberculosis.
Schön T; Juréen P; Chryssanthou E; Giske CG; Sturegård E; Kahlmeter G; Hoffner S; Angeby KA
Int J Tuberc Lung Dis; 2011 Apr; 15(4):502-9. PubMed ID: 21396210
[TBL] [Abstract][Full Text] [Related]
17. Activity of RBx 7644 and RBx 8700, new investigational oxazolidinones, against Mycobacterium tuberculosis infected murine macrophages.
Sood R; Rao M; Singhal S; Rattan A
Int J Antimicrob Agents; 2005 Jun; 25(6):464-8. PubMed ID: 15885988
[TBL] [Abstract][Full Text] [Related]
18. Lipiarmycin targets RNA polymerase and has good activity against multidrug-resistant strains of Mycobacterium tuberculosis.
Kurabachew M; Lu SH; Krastel P; Schmitt EK; Suresh BL; Goh A; Knox JE; Ma NL; Jiricek J; Beer D; Cynamon M; Petersen F; Dartois V; Keller T; Dick T; Sambandamurthy VK
J Antimicrob Chemother; 2008 Oct; 62(4):713-9. PubMed ID: 18587134
[TBL] [Abstract][Full Text] [Related]
19. Antimycobacterial activities of novel fluoroquinolones.
Senthilkumar P; Dinakaran M; Yogeeswari P; China A; Nagaraja V; Sriram D
Biomed Pharmacother; 2009 Jan; 63(1):27-35. PubMed ID: 18031974
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and in vitro antitubercular activity of a series of quinoline derivatives.
de Souza MV; Pais KC; Kaiser CR; Peralta MA; de L Ferreira M; Lourenço MC
Bioorg Med Chem; 2009 Feb; 17(4):1474-80. PubMed ID: 19188070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
